SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001787306-23-000077
Filing Date
2023-08-08
Accepted
2023-08-08 16:06:11
Documents
74
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q arqt-20230630.htm   iXBRL 10-Q 1151520
2 RULE 13A-14(A) CERTIFICATION CEO exhibit311ceoq22023.htm EX-31.1 10707
3 RULE 13A-14(A) CERTIFICATION CFO exhibit312cfoq22023.htm EX-31.2 10682
4 SECTION 1350 CERTIFICATIONS exhibit321ceocfoq22023.htm EX-32.1 7013
  Complete submission text file 0001787306-23-000077.txt   6940511

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT arqt-20230630.xsd EX-101.SCH 50480
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT arqt-20230630_cal.xml EX-101.CAL 70026
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT arqt-20230630_def.xml EX-101.DEF 237970
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT arqt-20230630_lab.xml EX-101.LAB 729224
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT arqt-20230630_pre.xml EX-101.PRE 467985
68 EXTRACTED XBRL INSTANCE DOCUMENT arqt-20230630_htm.xml XML 867145
Mailing Address 3027 TOWNSGATE ROAD SUITE 300 WESTLAKE VILLAGE CA 91361
Business Address 3027 TOWNSGATE ROAD SUITE 300 WESTLAKE VILLAGE CA 91361 805-418-5006
Arcutis Biotherapeutics, Inc. (Filer) CIK: 0001787306 (see all company filings)

IRS No.: 812974255 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39186 | Film No.: 231151208
SIC: 2834 Pharmaceutical Preparations